138 related articles for article (PubMed ID: 3631942)
1. Bactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers.
Standiford HC; Drusano GL; Forrest A; Tatem B; Plaisance K
Antimicrob Agents Chemother; 1987 Aug; 31(8):1177-82. PubMed ID: 3631942
[TBL] [Abstract][Full Text] [Related]
2. Serum inhibitory and bactericidal activity of ciprofloxacin following intravenous administration.
Dudley MN; Mandler HD; Mayer KH; Zinner SH
DICP; 1989 Jun; 23(6):456-60. PubMed ID: 2741478
[TBL] [Abstract][Full Text] [Related]
3. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
[TBL] [Abstract][Full Text] [Related]
4. The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
McNamee W; Drusano GL; Tatem BA; Standiford HC
J Antimicrob Chemother; 1984 Nov; 14(5):491-7. PubMed ID: 6096348
[TBL] [Abstract][Full Text] [Related]
5. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
Well M; Naber KG; Kinzig-Schippers M; Sörgel F
Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
[TBL] [Abstract][Full Text] [Related]
6. Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Wydra S; Onda H; Kinzig-Schippers M; Sörgel F; Naber KG
Antimicrob Agents Chemother; 2003 Dec; 47(12):3789-94. PubMed ID: 14638484
[TBL] [Abstract][Full Text] [Related]
7. Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously.
Dan M; Poch F; Quassem C; Kitzes R
Antimicrob Agents Chemother; 1994 Apr; 38(4):837-41. PubMed ID: 8031055
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion and bactericidal activity of intravenous ciprofloxacin compared with oral ciprofloxacin.
Naber KG; Theuretzbacher U; Moneva-Koucheva G; Stass H
Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):783-9. PubMed ID: 10614952
[TBL] [Abstract][Full Text] [Related]
10. Correlation of predicted serum bactericidal activities and values measured in volunteers.
Drusano G; Standiford H; Ryan P; McNamee W; Tatem B; Schimpff S
Eur J Clin Microbiol; 1986 Feb; 5(1):88-92. PubMed ID: 3084247
[TBL] [Abstract][Full Text] [Related]
11. Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin.
Echols R; Weinstein MP; O'Keeffe B; Shah A; Heller AH
J Antimicrob Chemother; 1994 Jan; 33(1):111-8. PubMed ID: 8157551
[TBL] [Abstract][Full Text] [Related]
12. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis.
Lagast H; Husson M; Klastersky J
J Antimicrob Chemother; 1985 Sep; 16(3):341-7. PubMed ID: 2932416
[TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
Beskid G; Siebelist J; McGarry CM; Cleeland R; Chan K; Keith DD
Chemotherapy; 1990; 36(2):109-16. PubMed ID: 2107064
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers.
Israel D; Gillum JG; Turik M; Harvey K; Ford J; Dalton H; Towle M; Echols R; Heller AH; Polk R
Antimicrob Agents Chemother; 1993 Oct; 37(10):2193-9. PubMed ID: 8257144
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
17. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1991)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kondou T; Kobayashi K; Satou K; Matsumiya H; Saito A
Jpn J Antibiot; 1995 Aug; 48(8):965-98. PubMed ID: 7474326
[TBL] [Abstract][Full Text] [Related]
18. [Bactericidal effect of cefotaxime-sulbactam and imipenem combined with gentamicin and/or ciprofloxacin against CTX-1 producing Klebsiella pneumoniae].
Archambaud M; Labau E; Clave D; Suc C
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):534-9. PubMed ID: 2677925
[TBL] [Abstract][Full Text] [Related]
19. Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
Lagast H; Zinner SH; Klastersky J
Antimicrob Agents Chemother; 1981 Oct; 20(4):539-41. PubMed ID: 6282198
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activity of carbamate-linked dual-action antibacterial Ro 24-4383.
Beskid G; Albrecht HA; Fallat V; Keith DD; Lipschitz ER; McGarry CM; McGarry DH; Rossman P; Siebelist J
Chemotherapy; 1991; 37(5):310-7. PubMed ID: 1804592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]